Lower dopamine transporter binding potential in striatum during depression

被引:210
作者
Meyer, JH
Krüger, S
Wilson, AK
Christensen, BK
Goulding, VS
Schaffer, A
Minifie, C
Houle, S
Hussey, D
Kennedy, SH
机构
[1] PET Imaging Ctr, Toronto, ON M5T 1R8, Canada
[2] Ctr Addict & Mental Hlth, Mood Div, Div Psychiat, Toronto, ON M5T 1R8, Canada
[3] Univ Toronto, Toronto, ON M5T 1R8, Canada
关键词
depression; dopamine; dopamine transporter; positron emission tomography;
D O I
10.1097/00001756-200112210-00052
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies suggest that there is a dopamine lowering process during major depressive episodes (MDE). To investigate this, we measured the dopamine transporter binding potential (DAT BP) in the striatum of depressed and healthy subjects using [C-11]RTI-32 PET. The DAT, a predominantly presynaptic receptor, decreases in density after chronic dopamine depletion and the BP is proportional to receptor density. In all striatal regions, subjects with MDE had significantly lower DAT BP. Low striatal DAT BP in MDE is consistent with a downregulation of DAT in response to a dopamine lowering process. There was also a strong, highly significant, inverse correlation between striatal DAT BP and neuropsychological tests of dopamine-implicated symptoms in patients (i.e. patients with lower DAT BP performed better). Lower DAT BP itself reduces extracellular clearance of dopamine. Patients who did not decrease their striatal DAT BP failed to compensate for low dopamine and showed greater impairment on dopamine related tests. NeuroReport 12:4121-4125 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:4121 / 4125
页数:5
相关论文
共 27 条
[1]  
[Anonymous], RECEPTOR TABLES
[2]   COCAINE AND 3-BETA-(4'-SUBSTITUTED PHENYL)TROPANE-2-BETA-CARBOXYLIC ACID ESTER AND AMIDE ANALOGS - NEW HIGH-AFFINITY AND SELECTIVE COMPOUNDS FOR THE DOPAMINE TRANSPORTER [J].
CARROLL, FI ;
KOTIAN, P ;
DEHGHANI, A ;
GRAY, JL ;
KUZEMKO, MA ;
PARHAM, KA ;
ABRAHAM, P ;
LEWIN, AH ;
BOJA, JW ;
KUHAR, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :379-388
[3]   THE DOPAMINE TRANSPORTER - IMMUNOCHEMICAL CHARACTERIZATION AND LOCALIZATION IN BRAIN [J].
CILIAX, BJ ;
HEILMAN, C ;
DEMCHYSHYN, LL ;
PRISTUPA, ZB ;
INCE, E ;
HERSCH, SM ;
NIZNIK, HB ;
LEVEY, AI .
JOURNAL OF NEUROSCIENCE, 1995, 15 (03) :1714-1723
[4]   DOPAMINE D(2) RECEPTORS IN DEPRESSION MEASURED WITH SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY [J].
DHAENEN, HA ;
BOSSUYT, A .
BIOLOGICAL PSYCHIATRY, 1994, 35 (02) :128-132
[5]   Dopamine and depression - Striatal dopamine D-2 receptor SPECT before and after antidepressant therapy [J].
Ebert, D ;
Feistel, H ;
Loew, T ;
Pirner, A .
PSYCHOPHARMACOLOGY, 1996, 126 (01) :91-94
[6]  
First MB, 2002, STRUCTURED CLIN INTE
[7]  
Ginovart N, 1997, SYNAPSE, V25, P321, DOI 10.1002/(SICI)1098-2396(199704)25:4<321::AID-SYN2>3.0.CO
[8]  
2-C
[9]   Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter [J].
Gordon, I ;
Weizman, R ;
Rehavi, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (01) :27-30
[10]   [C-11]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: Implications for the symptomatic threshold [J].
Guttman, M ;
Burkholder, J ;
Kish, SJ ;
Hussey, D ;
Wilson, A ;
DaSilva, J ;
Houle, S .
NEUROLOGY, 1997, 48 (06) :1578-1583